VNDA logo

Vanda Pharmaceuticals (VNDA) Accounts Payable

Annual Accounts Payable

$7.14 M
-$5.54 M-43.70%

31 December 2023

VNDA Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$5.81 M
+$3.54 M+156.35%

30 September 2024

VNDA Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VNDA Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.7%+66.5%
3 y3 years+581.1%+347.2%
5 y5 years--

VNDA Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-43.7%+672.4%-64.6%+528.0%
5 y5 years-43.7%+672.4%-64.6%+528.0%
alltimeall time-96.8%+2389.6%-64.6%+2242.3%

Vanda Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$5.81 M(+156.4%)
June 2024
-
$2.27 M(-47.8%)
Mar 2024
-
$4.34 M(-39.2%)
Dec 2023
$7.14 M(-43.7%)
$7.14 M(+104.8%)
Sept 2023
-
$3.49 M(+60.7%)
June 2023
-
$2.17 M(-42.9%)
Mar 2023
-
$3.80 M(-70.1%)
Dec 2022
$12.69 M(+1271.9%)
$12.69 M(-5.5%)
Sept 2022
-
$13.43 M(-18.2%)
June 2022
-
$16.41 M(+14.6%)
Mar 2022
-
$14.33 M(+1448.9%)
Dec 2021
$925.00 K(-11.8%)
$925.00 K(-28.8%)
Sept 2021
-
$1.30 M(-38.6%)
June 2021
-
$2.12 M(+101.8%)
Dec 2020
$1.05 M(+58.7%)
$1.05 M(-35.7%)
June 2015
-
$1.63 M(+9.5%)
Mar 2015
-
$1.49 M(+172.4%)
Sept 2014
-
$547.00 K(+120.6%)
June 2014
-
$248.00 K(-74.0%)
Mar 2014
-
$953.00 K(+44.2%)
Dec 2013
$661.00 K(+130.3%)
$661.00 K(+79.1%)
Sept 2013
-
$369.00 K(-68.4%)
June 2013
-
$1.17 M(+4.9%)
Mar 2013
-
$1.11 M(+287.8%)
Dec 2012
$287.00 K(-71.2%)
$287.00 K(-73.7%)
Sept 2012
-
$1.09 M(-35.5%)
June 2012
-
$1.69 M(+116.5%)
Mar 2012
-
$780.00 K(-21.7%)
DateAnnualQuarterly
Dec 2011
$996.00 K(+53.7%)
$996.00 K(-25.3%)
Sept 2011
-
$1.33 M(-0.3%)
June 2011
-
$1.34 M(+60.3%)
Mar 2011
-
$834.00 K(+28.7%)
Dec 2010
$648.00 K(-73.3%)
$648.00 K(+119.3%)
Sept 2010
-
$295.50 K(-71.0%)
June 2010
-
$1.02 M(+17.5%)
Mar 2010
-
$867.80 K(-64.2%)
Dec 2009
$2.42 M(+373.1%)
$2.42 M(-61.8%)
Sept 2009
-
$6.35 M(-8.3%)
June 2009
-
$6.92 M(+388.7%)
Mar 2009
-
$1.42 M(+176.2%)
Dec 2008
$512.40 K(-82.9%)
$512.40 K(-43.0%)
Sept 2008
-
$899.00 K(-84.6%)
June 2008
-
$5.83 M(+219.1%)
Mar 2008
-
$1.83 M(-38.9%)
Dec 2007
$2.99 M(+7.4%)
$2.99 M(-13.3%)
Sept 2007
-
$3.45 M(+32.5%)
June 2007
-
$2.60 M(+29.4%)
Mar 2007
-
$2.01 M(-27.8%)
Dec 2006
$2.78 M(+23.4%)
$2.78 M(+31.8%)
Sept 2006
-
$2.11 M(-58.3%)
June 2006
-
$5.06 M(+49.9%)
Mar 2006
-
$3.38 M(+49.8%)
Dec 2005
$2.25 M(+213.8%)
$2.25 M
Dec 2004
$718.60 K(-99.7%)
-
Dec 2003
$226.10 M(+11.5%)
-
Dec 2002
$202.76 M
-

FAQ

  • What is Vanda Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Vanda Pharmaceuticals?
  • What is Vanda Pharmaceuticals annual accounts payable year-on-year change?
  • What is Vanda Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Vanda Pharmaceuticals?
  • What is Vanda Pharmaceuticals quarterly accounts payable year-on-year change?

What is Vanda Pharmaceuticals annual accounts payable?

The current annual accounts payable of VNDA is $7.14 M

What is the all time high annual accounts payable for Vanda Pharmaceuticals?

Vanda Pharmaceuticals all-time high annual accounts payable is $226.10 M

What is Vanda Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, VNDA annual accounts payable has changed by -$5.54 M (-43.70%)

What is Vanda Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of VNDA is $5.81 M

What is the all time high quarterly accounts payable for Vanda Pharmaceuticals?

Vanda Pharmaceuticals all-time high quarterly accounts payable is $16.41 M

What is Vanda Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, VNDA quarterly accounts payable has changed by +$2.32 M (+66.54%)